MA29653B1 - Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent - Google Patents

Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Info

Publication number
MA29653B1
MA29653B1 MA30610A MA30610A MA29653B1 MA 29653 B1 MA29653 B1 MA 29653B1 MA 30610 A MA30610 A MA 30610A MA 30610 A MA30610 A MA 30610A MA 29653 B1 MA29653 B1 MA 29653B1
Authority
MA
Morocco
Prior art keywords
preparing
pharmaceutical compositions
compositions containing
analog compounds
camptothecin analog
Prior art date
Application number
MA30610A
Other languages
English (en)
Inventor
Gilbert Lavielle
Patrick Hautefaye
Alain Pierre
John Hickman
Stephane Leonce
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of MA29653B1 publication Critical patent/MA29653B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

NOUVEAUX COMPOSES ANALOGUES DE LA CAMPTOTHECINE, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT Composé de formule (I) : dans laquelle : ¿ R1, R2, R3, R4, R5, R80, R90, R81, R91, Alk et G sont tels que définis dans la description. Médicaments.
MA30610A 2005-08-05 2008-01-28 Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent MA29653B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0508364A FR2889527A1 (fr) 2005-08-05 2005-08-05 Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
MA29653B1 true MA29653B1 (fr) 2008-07-01

Family

ID=36216903

Family Applications (1)

Application Number Title Priority Date Filing Date
MA30610A MA29653B1 (fr) 2005-08-05 2008-01-28 Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Country Status (19)

Country Link
US (1) US20100168149A1 (fr)
EP (1) EP1910377A2 (fr)
JP (1) JP2009503039A (fr)
KR (1) KR20080032007A (fr)
CN (1) CN101238133A (fr)
AR (1) AR056189A1 (fr)
AU (1) AU2006277863A1 (fr)
BR (1) BRPI0614608A2 (fr)
CA (1) CA2617957C (fr)
EA (1) EA014689B1 (fr)
FR (1) FR2889527A1 (fr)
GE (1) GEP20115243B (fr)
MA (1) MA29653B1 (fr)
MX (1) MX2008001560A (fr)
MY (1) MY150497A (fr)
NO (1) NO20081169L (fr)
UA (1) UA95253C2 (fr)
WO (1) WO2007017585A2 (fr)
ZA (1) ZA200801991B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2889528B1 (fr) * 2005-08-05 2007-09-07 Servier Lab Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2900652C (fr) 2013-02-15 2021-05-04 Kala Pharmaceuticals, Inc. Composes therapeutiques et utilisations de ceux-ci
CN107915751A (zh) 2013-02-20 2018-04-17 卡拉制药公司 治疗性化合物和其用途
US9688688B2 (en) 2013-02-20 2017-06-27 Kala Pharmaceuticals, Inc. Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
WO2015066482A1 (fr) 2013-11-01 2015-05-07 Kala Pharmaceuticals, Inc. Formes cristallines de composés thérapeutiques et leurs utilisations
US9890173B2 (en) 2013-11-01 2018-02-13 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
CN106188079A (zh) * 2016-07-09 2016-12-07 兰州大学 喜树碱7‑位哌嗪硫脲类化合物、制备方法和用途
MX2019002629A (es) 2016-09-08 2019-10-07 Kala Pharmaceuticals Inc Formas cristalinas de compuestos terapéuticos y usos de los mismos.
AU2017324713B2 (en) 2016-09-08 2020-08-13 KALA BIO, Inc. Crystalline forms of therapeutic compounds and uses thereof
AU2017324716B2 (en) 2016-09-08 2020-08-13 KALA BIO, Inc. Crystalline forms of therapeutic compounds and uses thereof
CN110357897A (zh) * 2019-07-26 2019-10-22 上海健康医学院 一种具有抗肿瘤活性的喜树碱衍生物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6111107A (en) * 1997-11-20 2000-08-29 Enzon, Inc. High yield method for stereoselective acylation of tertiary alcohols
US6699876B2 (en) * 1999-11-18 2004-03-02 Les Laboratoires Servier Camptothecin analogue compounds
FR2801309B1 (fr) * 1999-11-18 2002-01-04 Adir Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6403604B1 (en) * 2001-03-01 2002-06-11 California Pacific Medical Center Nitrogen-based camptothecin derivatives
US6933302B2 (en) * 2002-06-03 2005-08-23 California Pacific Medical Center Nitrogen-based homo-camptothecin derivatives
CN100443486C (zh) * 2002-09-11 2008-12-17 中国医学科学院药物研究所 7-酯化和7,20-双酯化的喜树碱衍生物及其制法和其药物组合物与用途
FR2889528B1 (fr) * 2005-08-05 2007-09-07 Servier Lab Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
NO20081169L (no) 2008-03-05
CA2617957C (fr) 2011-09-20
CA2617957A1 (fr) 2007-02-15
EA014689B1 (ru) 2010-12-30
BRPI0614608A2 (pt) 2016-11-16
MY150497A (en) 2014-01-30
ZA200801991B (en) 2009-08-26
UA95253C2 (ru) 2011-07-25
JP2009503039A (ja) 2009-01-29
AR056189A1 (es) 2007-09-26
FR2889527A1 (fr) 2007-02-09
EP1910377A2 (fr) 2008-04-16
AU2006277863A1 (en) 2007-02-15
WO2007017585A3 (fr) 2007-04-12
WO2007017585A2 (fr) 2007-02-15
MX2008001560A (es) 2008-02-15
EA200800393A1 (ru) 2008-08-29
CN101238133A (zh) 2008-08-06
US20100168149A1 (en) 2010-07-01
KR20080032007A (ko) 2008-04-11
GEP20115243B (en) 2011-06-27

Similar Documents

Publication Publication Date Title
MY148429A (en) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
EA201170768A1 (ru) Органические соединения
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
TN2009000483A1 (fr) Derives de 7-alkynyl-1-8-naphthyridones, leur preparation et leur application en therapeutique
NO20081169L (no) Nye camptothecinanalogforbindelser, en fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
TW200626553A (en) Novel compounds
MY142474A (en) 1h-quinazoline-2,4-diones
DK1730147T3 (da) Substituerede 1,4,8-triazaspiro[4.5]decan-2-on-forbindelser til behandling af fedme
TW200714598A (en) Urea derivatives, methods for their manufacture, and uses therefor
TW200833371A (en) Process for solid formulations
EA200970432A1 (ru) 8-сульфонил-1,3,4,8-тетрагидро-2н-[1,4]оксазепино[6,7-e] индольные производные и их использование в качестве 5-нт6 рецепторных лигандов
DK1869038T3 (da) Substituerede 5,6,7,8-tetrahydro-imidazol[1,2-a]pyridin-2-ylamin-forbindelser og deres anvendelse til fremstilling af lægemidler
MA29648B1 (fr) Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
SE0101978D0 (sv) New compounds
UA91646C2 (ru) Соединения индола, способ их получения и фармацевтическая композиция (варианты), которая их содержит
ATE478655T1 (de) Pharmazeutische zusammensetzung zur oralen verabreichung
TN2012000267A1 (fr) Nouveaux derives azabicyclo [3.1.0] hex- 2 -yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
TN2010000542A1 (fr) Nouveaux derives azabicylco[3.2.0]hept 3-yl leur procede de preparation et les compositons pharmaceutiques qui les contiennent
GB0322994D0 (en) Organic compounds
UA61543C2 (en) A METHOD FOR THE PREPARATION OF COMPLEX COMPOUND OF PLATINUM (II) 3 n-DNA
TN2009000216A1 (fr) Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
TW200531691A (en) Tricyclic imidazopyridines and novel intermediates for the synthesis thereof
TN2009000087A1 (fr) Nouveaux derives de diosmetine,leur procede de preparation et les compositions pharmaceutiques qui la contiennent